$1.86
0.053.04%
Ultimo aggiornamento: 11:17 AM
Comments
Loading...
Attività di insider trading
Tieni traccia delle ultime attività di insider trading Akebia Therapeutics. Rimani informato sui recenti acquisti, vendite e impatto sul mercato per le azioni Akebia Therapeutics.
Cos'è l'attività interna?
L'attività di insider trading coinvolge soggetti interni all'azienda, come dirigenti, direttori e dipendenti, impegnati in transazioni sulle azioni della propria azienda. Le transazioni di acquisto e vendita degli addetti ai lavori forniscono informazioni preziose sulla loro fiducia nelle prestazioni future dell'azienda.
Cosa stanno facendo gli Akebia Therapeutics Inc addetti ai lavori?
Gli addetti ai lavori non hanno segnalato acquisti/vendite negli ultimi 30 giorni.
Notevoli acquisti e vendite recenti di insider
Non ci sono stati acquisti o vendite da parte di Insider negli ultimi 90 giorni.
Statistiche sulla proprietà per Akebia Therapeutics Inc
Numero di azioni emesse
265.366M
Azioni possedute dagli insider
9.153M
Percentuale posseduta dagli Insider
3.45%
Azioni possedute dagli investitori istituzionali
76.392M
Percentuale posseduta dagli investitori istituzionali
28.8%
Jul 01, 2025 | SVP, CFO, CBO & TREASURER | -41.31K | $3.67 | -$151.62K | SELL | -7.58% | 503.59K | Jun 30 | ||
Jun 11, 2025 | SVP, CHIEF ACCOUNTING OFFICER | 0.00 | $2.84 | -$34.95K | SELL-OPTIONS | 0.00% | 266.91K | Jun 09 | ||
Jun 05, 2025 | SVP, CHIEF ACCOUNTING OFFICER | -13.33K | $3.53 | -$47.07K | SELL | -4.76% | 266.91K | Jun 04 | ||
Mar 04, 2025 | CEO AND PRESIDENT | -46.41K | $1.83 | -$84.93K | SELL | -1.74% | 2.62M | Mar 03 | ||
Mar 04, 2025 | SVP, CHIEF MEDICAL OFFICER | -7.14K | $1.83 | -$13.07K | SELL | -0.88% | 809.09K | Mar 03 | ||
Feb 04, 2025 | CEO AND PRESIDENT | 556.75K | $2.10 | -$302.93K | GRANT | 26.42% | 2.66M | Jan 31 - Feb 03 | ||
Feb 04, 2025 | SVP, CHIEF MEDICAL OFFICER | 144.39K | $2.10 | -$106.06K | GRANT | 21.49% | 816.23K | Jan 31 - Feb 03 | ||
Feb 04, 2025 | SVP, CHIEF ACCOUNTING OFFICER | 54.80K | $2.10 | -$63.42K | GRANT | 24.31% | 280.25K | Jan 31 - Feb 03 | ||
Feb 04, 2025 | CHIEF COMMERCIAL OFFICER | 139.28K | $2.10 | -$116.80K | GRANT | 45.92% | 442.58K | Jan 31 - Feb 03 | ||
May 14, 2024 | SVP, CHIEF LEGAL OFFICER | -12.02K | $1.26 | -$15.14K | SELL | -1.81% | 651.24K | May 13 | ||
May 14, 2024 | SVP, CHIEF OPERATING OFFICER | -34.84K | $1.26 | -$43.90K | SELL | -4.93% | 672.09K | May 13 | ||
May 09, 2024 | SVP, CHIEF MEDICAL OFFICER | -27.00K | $1.15 | -$31.05K | SELL | -3.88% | 668.84K | Aug 25 | ||
Mar 01, 2024 | SVP, CHIEF OPERATING OFFICER | -8.66K | $1.58 | -$13.68K | SELL | -1.21% | 706.93K | Feb 29 | ||
Mar 01, 2024 | SVP, CHIEF LEGAL OFFICER | -5.97K | $1.58 | -$9.44K | SELL | -0.89% | 663.26K | Feb 29 | ||
Mar 01, 2024 | CEO AND PRESIDENT | -46.57K | $1.58 | -$73.58K | SELL | -2.16% | 2.10M | Feb 29 | ||
Mar 01, 2024 | SVP, CHIEF MEDICAL OFFICER | -7.17K | $1.58 | -$11.33K | SELL | -1.02% | 695.84K | Feb 29 | ||
Feb 29, 2024 | SVP, CHIEF LEGAL OFFICER | -7.41K | $1.52 | -$11.26K | SELL | -1.10% | 669.23K | Feb 27 | ||
Feb 29, 2024 | SVP, CHIEF OPERATING OFFICER | -10.74K | $1.52 | -$16.33K | SELL | -1.48% | 715.59K | Feb 27 | ||
Feb 29, 2024 | SVP, CHIEF MEDICAL OFFICER | -8.37K | $1.52 | -$12.72K | SELL | -1.18% | 703.01K | Feb 27 | ||
Feb 29, 2024 | CEO AND PRESIDENT | -37.73K | $1.52 | -$57.35K | SELL | -1.72% | 2.15M | Feb 27 | ||
Feb 02, 2024 | CEO AND PRESIDENT | 557.01K | $1.68 | -$78.10K | GRANT | 34.13% | 2.19M | Jan 31 - Feb 01 | ||
Feb 02, 2024 | SVP, CHIEF MEDICAL OFFICER | 177.89K | $1.68 | -$40.84K | GRANT | 33.34% | 711.38K | Jan 31 - Feb 01 | ||
May 25, 2023 | SVP, CHIEF LEGAL OFFICER | 136.81K | $1.22 | -$77.27K | GRANT | 35.30% | 524.34K | May 24 - May 25 | ||
May 25, 2023 | SVP, CHIEF OPERATING OFFICER | 104.52K | $1.22 | -$116.76K | GRANT | 22.26% | 574.04K | May 24 - May 25 | ||
May 18, 2023 | SVP, CHIEF MEDICAL OFFICER | -63.57K | $1.07 | -$67.89K | SELL | -10.70% | 530.49K | May 16 | ||
May 18, 2023 | SVP, CFO AND TREASURER | -63.57K | $1.07 | -$67.89K | SELL | -12.46% | 446.48K | May 16 | ||
Mar 03, 2023 | CEO AND PRESIDENT | -91.87K | $0.88 | -$80.61K | SELL | -5.34% | 1.63M | Mar 01 | ||
Mar 03, 2023 | SVP, CHIEF LEGAL OFFICER | -13.03K | $0.88 | -$11.44K | SELL | -4.34% | 287.53K | Mar 01 | ||
Mar 03, 2023 | SVP, CHIEF MEDICAL OFFICER | -14.12K | $0.88 | -$12.39K | SELL | -2.32% | 594.05K | Mar 01 | ||
Mar 03, 2023 | SVP, CHIEF OPERATING OFFICER | -20.41K | $0.88 | -$17.91K | SELL | -7.04% | 269.51K | Mar 01 | ||
Mar 03, 2023 | SVP, CFO AND TREASURER | -7.21K | $0.88 | -$6.33K | SELL | -1.39% | 510.05K | Mar 01 | ||
Mar 01, 2023 | CEO AND PRESIDENT | -38.63K | $0.81 | -$31.42K | SELL | -2.20% | 1.72M | Feb 27 | ||
Mar 01, 2023 | SVP, CHIEF MEDICAL OFFICER | -7.54K | $0.81 | -$6.13K | SELL | -1.22% | 608.18K | Feb 27 | ||
Mar 01, 2023 | SVP, CHIEF OPERATING OFFICER | -10.09K | $0.81 | -$8.21K | SELL | -3.36% | 289.93K | Feb 27 | ||
Mar 01, 2023 | SVP, CFO AND TREASURER | -7.54K | $0.81 | -$6.13K | SELL | -1.44% | 517.26K | Feb 27 | ||
Mar 01, 2023 | SVP, CHIEF LEGAL OFFICER | -6.68K | $0.81 | -$5.43K | SELL | -2.17% | 300.56K | Feb 27 | ||
Sep 01, 2022 | SVP, CHIEF MEDICAL OFFICER | -1.15K | $0.36 | -$415.79 | SELL | -0.27% | 418.02K | Aug 31 | ||
Jun 07, 2022 | — | -4.57K | $0.36 | -$1.65K | SELL | -9.52% | 43.43K | Jun 03 | ||
Mar 02, 2022 | CEO AND PRESIDENT | 214.10K | $2.17 | -$171.14K | GRANT | 16.61% | 1.50M | Feb 28 - Mar 01 | ||
Mar 02, 2022 | SVP, CHIEF MEDICAL OFFICER | 44.94K | $2.16 | -$32.56K | GRANT | 26.02% | 217.66K | Feb 28 - Mar 01 | ||
Mar 02, 2022 | SVP, CHIEF ACCOUNTING OFFICER | 36.89K | $2.15 | -$8.50K | GRANT | 111.55% | 69.95K | Feb 28 | ||
Mar 02, 2022 | SVP, CHIEF OPERATING OFFICER | 28.47K | $2.17 | -$46.64K | GRANT | 10.60% | 297.02K | Feb 28 - Mar 01 | ||
Mar 02, 2022 | SVP, CCO | 36.82K | $2.16 | -$28.52K | GRANT | 26.87% | 173.84K | Feb 28 - Mar 01 | ||
Mar 02, 2022 | SVP, CHIEF LEGAL OFFICER | 28.94K | $2.17 | -$45.62K | GRANT | 10.51% | 304.24K | Feb 28 - Mar 01 | ||
Mar 02, 2022 | SVP, CFO AND TREASURER | 51.80K | $2.16 | -$17.69K | GRANT | 67.44% | 128.60K | Feb 28 - Mar 01 | ||
Jan 05, 2022 | SVP, CHIEF ACCOUNTING OFFICER | -5.83K | $2.29 | -$13.34K | SELL | -14.99% | 33.07K | Jan 03 | ||
Sep 02, 2021 | SVP, CHIEF MEDICAL OFFICER | -1.04K | $2.83 | -$2.95K | SELL | -0.60% | 171.22K | Aug 31 | ||
Jun 09, 2021 | — | -4.57K | $3.32 | -$15.16K | SELL | -8.69% | 48.00K | Jun 07 | ||
Apr 01, 2021 | SVP, CCO | -952.00 | $3.40 | -$3.24K | SELL | -0.69% | 137.03K | Apr 01 | ||
Apr 01, 2021 | SVP, CFO AND TREASURER | -790.00 | $3.40 | -$2.69K | SELL | -1.02% | 76.80K | Apr 01 | ||
Apr 01, 2021 | SVP, CHIEF LEGAL OFFICER | -1.06K | $3.40 | -$3.60K | SELL | -0.39% | 272.30K | Apr 01 | ||
Apr 01, 2021 | SVP, CHIEF OPERATING OFFICER | -1.21K | $3.40 | -$4.12K | SELL | -0.45% | 265.55K | Apr 01 | ||
Apr 01, 2021 | CEO AND PRESIDENT | -4.11K | $3.40 | -$13.97K | SELL | -0.35% | 1.18M | Apr 01 | ||
Apr 01, 2021 | SVP, CHIEF MEDICAL OFFICER | -1.08K | $3.40 | -$3.68K | SELL | -0.63% | 170.76K | Apr 01 | ||
Mar 02, 2021 | CEO AND PRESIDENT | 187.41K | $3.40 | -$169.77K | GRANT | 19.51% | 1.15M | Feb 26 - Mar 01 | ||
Mar 02, 2021 | CCO | 55.25K | $3.40 | -$22.92K | GRANT | 75.10% | 128.82K | Feb 26 - Mar 01 | ||
Mar 02, 2021 | SVP, CHIEF LEGAL OFFICER | 47.72K | $3.40 | -$48.51K | GRANT | 22.15% | 263.17K | Feb 26 - Mar 01 | ||
Mar 02, 2021 | SVP, CHIEF OPERATING OFFICER | 47.45K | $3.40 | -$49.40K | GRANT | 22.85% | 255.11K | Feb 26 - Mar 01 | ||
Mar 02, 2021 | SVP, CHIEF MEDICAL OFFICER | 62.44K | $3.40 | -$25.67K | GRANT | 63.07% | 161.44K | Feb 26 - Mar 01 | ||
Jun 09, 2020 | — | 9.13K | $12.10 | -$55.26K | GRANT OR AWARD | 31.82% | 37.83K | Jun 05 - Jun 08 | ||
Jun 09, 2020 | — | 9.13K | $12.08 | -$55.17K | GRANT OR AWARD | 30.72% | 38.86K | Jun 05 - Jun 08 | ||
Jun 09, 2020 | — | 9.13K | $12.05 | -$55.03K | GRANT OR AWARD | 60.89% | 24.13K | Jun 05 - Jun 08 | ||
Jun 02, 2020 | — | -6.43K | $11.58 | -$74.41K | SELL | -8.03% | 73.57K | Jun 01 | ||
Mar 02, 2020 | — | 58.03K | $8.70 | -$60.66K | GRANT OR AWARD | 39.49% | 204.96K | Feb 28 | ||
Mar 02, 2020 | — | 54.95K | $8.70 | -$61.33K | GRANT OR AWARD | 34.82% | 212.76K | Feb 28 | ||
Mar 02, 2020 | — | 23.02K | $8.70 | -$60.69K | GRANT OR AWARD | 18.93% | 144.64K | Feb 28 | ||
Mar 02, 2020 | — | 26.55K | $8.70 | -$30.05K | GRANT OR AWARD | 45.66% | 84.68K | Feb 28 | ||
Nov 22, 2019 | — | 5.80K | $3.43 | $19.89K | BUY | 24.24% | 29.73K | Nov 20 | ||
Nov 22, 2019 | — | 15.00K | $3.52 | $52.80K | BUY | 109.49% | 28.70K | Nov 20 | ||
Nov 22, 2019 | SVP, CHIEF MEDICAL OFFICER | 27.00K | $3.58 | $96.66K | BUY | 270.00% | 37.00K | Nov 20 | ||
Nov 21, 2019 | CEO AND PRESIDENT | 50.00K | $3.44 | $172.00K | BUY | 5.76% | 918.78K | Nov 20 | ||
Nov 21, 2019 | — | 50.00K | $3.41 | $170.50K | BUY | 364.96% | 63.70K | Nov 20 | ||
Feb 16, 2018 | — | -1.00K | $14.62 | -$14.62K | SELL | -4.44% | 21.50K | Feb 15 | ||
Oct 04, 2017 | — | -1.19K | $19.64 | -$23.33K | SELL | -5.02% | 22.50K | Oct 02 | ||
Oct 04, 2017 | SVP, GENERAL COUNSEL, SEC. | -7.80K | $19.89 | -$155.19K | SELL | -7.12% | 101.80K | Oct 02 | ||
Oct 04, 2017 | SVP, CHIEF BUSINESS OFFICER | -1.40K | $19.64 | -$27.46K | SELL | -1.44% | 95.83K | Oct 02 | ||
Oct 02, 2017 | SVP, CHIEF BUSINESS OFFICER | -5.00K | $19.30 | -$96.50K | SELL | -4.89% | 97.22K | Sep 28 | ||
Aug 17, 2017 | SVP, CHIEF BUSINESS OFFICER | -5.00K | $15.00 | -$75.00K | SELL | -4.66% | 102.22K | Aug 15 | ||
Jul 11, 2017 | DIRECTOR | 1.03M | $14.50 | $15.00M | BUY | 51.66% | 3.04M | Jul 05 | ||
Jul 06, 2017 | SVP, CHIEF BUSINESS OFFICER | -1.40K | $14.26 | -$19.95K | SELL | -1.29% | 107.22K | Jul 03 | ||
Jul 06, 2017 | SVP, GENERAL COUNSEL, SEC. | -1.55K | $14.26 | -$22.16K | SELL | -1.40% | 109.61K | Jul 03 | ||
Jul 06, 2017 | — | -990.00 | $14.27 | -$14.13K | SELL | -4.01% | 23.69K | Jul 03 | ||
Apr 04, 2017 | SVP, CHIEF BUSINESS OFFICER | -1.40K | $9.18 | -$12.86K | SELL | -1.27% | 108.62K | Apr 03 | ||
Apr 04, 2017 | — | -991.00 | $9.20 | -$9.12K | SELL | -3.86% | 24.68K | Apr 03 | ||
Apr 04, 2017 | SVP, GENERAL COUNSEL, SEC. | -1.56K | $9.18 | -$14.28K | SELL | -1.40% | 109.86K | Apr 03 | ||
Jan 03, 2017 | SVP, CHIEF BUSINESS OFFICER | -1.63K | $10.49 | -$17.09K | SELL | -2.26% | 70.52K | Jan 01 | ||
Jan 03, 2017 | — | -1.98K | $10.46 | -$20.71K | SELL | -7.16% | 25.67K | Jan 03 | ||
Jan 03, 2017 | SVP, GENERAL COUNSEL, SEC. | -1.81K | $10.49 | -$18.99K | SELL | -2.14% | 82.91K | Jan 01 | ||
Oct 04, 2016 | — | -1.98K | $8.96 | -$17.75K | SELL | -6.69% | 27.65K | Oct 03 | ||
Oct 04, 2016 | SVP, CHIEF BUSINESS OFFICER | -1.40K | $8.95 | -$12.55K | SELL | -1.90% | 72.15K | Oct 01 | ||
Oct 04, 2016 | SVP, GENERAL COUNSEL, SEC. | -1.56K | $8.95 | -$13.93K | SELL | -1.82% | 83.92K | Oct 01 | ||
Jul 07, 2016 | — | -1.98K | $7.48 | -$14.82K | SELL | -6.26% | 29.63K | Jul 06 | ||
Jul 06, 2016 | SVP, CHIEF BUSINESS OFFICER | -1.40K | $7.47 | -$10.47K | SELL | -1.87% | 73.55K | Jul 05 | ||
Jul 06, 2016 | SVP, GENERAL COUNSEL, SEC. | -1.56K | $7.47 | -$11.63K | SELL | -1.79% | 85.47K | Jul 05 | ||
Apr 05, 2016 | SVP, GENERAL COUNSEL, SEC. | -1.56K | $9.41 | -$14.64K | SELL | -1.79% | 85.53K | Apr 04 | ||
Apr 05, 2016 | SVP, CHIEF BUSINESS OFFICER | -1.40K | $9.41 | -$13.18K | SELL | -1.83% | 74.96K | Apr 04 | ||
Jan 06, 2016 | SVP, GENERAL COUNSEL, SEC. | -1.81K | $12.28 | -$22.24K | SELL | -2.73% | 64.58K | Jan 04 | ||
Oct 05, 2015 | DIRECTOR | -996.00 | $8.65 | -$8.62K | SELL | -3.05% | 31.61K | Oct 02 | ||
Oct 05, 2015 | SVP, GENERAL COUNSEL, SEC. | -1.48K | $8.67 | -$12.86K | SELL | -2.22% | 65.26K | Oct 02 | ||
Jul 06, 2015 | DIRECTOR | -996.00 | $9.53 | -$9.49K | SELL | -2.96% | 32.60K | Jul 02 | ||
Jul 06, 2015 | SVP, GENERAL COUNSEL, SEC. | -1.48K | $9.54 | -$14.16K | SELL | -2.18% | 66.74K | Jul 02 | ||
Apr 22, 2015 | DIRECTOR | 420.00K | $8.25 | $3.46M | BUY | 26.54% | 2.00M | Apr 22 | ||
Apr 06, 2015 | DIRECTOR | 984.00 | $9.30 | $9.78K | GRANT | 8.92% | 12.02K | Apr 01 - Apr 02 | ||
Apr 06, 2015 | SVP, GENERAL COUNSEL, SEC. | 3.06K | $9.30 | $29.69K | GRANT | 4.18% | 76.09K | Apr 01 - Apr 02 | ||
Jan 05, 2015 | VP GENERAL COUNSEL & SECRETARY | 2.82K | $11.55 | $33.18K | GRANT | 4.02% | 73.04K | Jan 01 - Jan 02 | ||
Jan 05, 2015 | DIRECTOR | 985.00 | $11.55 | $11.64K | GRANT | 8.33% | 12.81K | Jan 01 - Jan 02 | ||
Dec 29, 2014 | CEO AND PRESIDENT | 1.00K | $11.57 | $11.57K | BUY | 2.11% | 48.35K | Dec 29 | ||
Dec 29, 2014 | DIRECTOR | 11.83K | $11.39 | $140.18K | GRANT | ∞ | 11.83K | Dec 23 - Dec 26 | ||
Dec 22, 2014 | CEO AND PRESIDENT | 1.00K | $11.92 | $11.92K | BUY | 2.16% | 47.35K | Dec 22 | ||
Dec 18, 2014 | CEO AND PRESIDENT | 1.00K | $11.34 | $11.34K | BUY | 2.21% | 46.35K | Dec 15 | ||
Dec 02, 2014 | DIRECTOR | 5.00K | $11.92 | $59.59K | BUY | ∞ | 5.00K | Dec 02 | ||
Dec 01, 2014 | SVP, CFO & TREASURER | 1.00K | $13.22 | $13.22K | BUY | 25.00% | 5.00K | Nov 26 | ||
Nov 26, 2014 | DIRECTOR | 5.00K | $13.18 | $65.90K | BUY | 0.32% | 1.58M | Nov 25 | ||
Nov 25, 2014 | DIRECTOR | 5.00K | $13.88 | $69.40K | BUY | 0.32% | 1.58M | Nov 24 | ||
Nov 24, 2014 | DIRECTOR | 5.00K | $14.73 | $73.65K | BUY | 0.32% | 1.57M | Nov 21 | ||
Nov 21, 2014 | DIRECTOR | 5.00K | $14.70 | $73.50K | BUY | 0.32% | 1.57M | Nov 20 | ||
Nov 20, 2014 | DIRECTOR | 5.00K | $14.85 | $74.25K | BUY | 0.32% | 1.56M | Nov 19 | ||
Nov 19, 2014 | DIRECTOR | 5.00K | $13.84 | $69.20K | BUY | 0.32% | 1.56M | Nov 18 | ||
Nov 18, 2014 | DIRECTOR | 5.00K | $12.94 | $64.70K | BUY | 0.32% | 1.55M | Nov 17 | ||
Nov 17, 2014 | DIRECTOR | 5.00K | $11.91 | $59.55K | BUY | 0.32% | 1.55M | Nov 14 | ||
Nov 14, 2014 | DIRECTOR | 5.00K | $11.56 | $57.80K | BUY | 0.33% | 1.54M | Nov 13 | ||
Nov 14, 2014 | DIRECTOR | 1.30K | $11.82 | $15.36K | BUY | ∞ | 1.30K | Nov 13 | ||
Nov 13, 2014 | CEO AND PRESIDENT | 31.50K | $0.78 | $24.64K | BUY | 227.44% | 45.35K | Nov 11 - Nov 12 | ||
Nov 13, 2014 | DIRECTOR | 5.00K | $11.90 | $59.52K | BUY | 0.33% | 1.54M | Nov 12 | ||
Mar 27, 2014 | 10% OWNER | 3.41M | $17.00 | $3.10M | BUY | ∞ | 3.41M | Mar 25 | ||
Mar 27, 2014 | DIRECTOR | 1.50K | $17.00 | $25.50K | BUY | ∞ | 1.50K | Mar 25 | ||
Mar 27, 2014 | SEE REMARKS | 3.50K | $17.00 | $59.50K | BUY | 4.82% | 76.12K | Mar 25 | ||
Mar 27, 2014 | DIRECTOR | 1.53M | $17.00 | $1.55M | BUY | ∞ | 1.53M | Mar 25 | ||
Mar 27, 2014 | PRESIDENT AND CEO | 13.85K | $17.00 | $235.45K | BUY | ∞ | 13.85K | Mar 25 | ||
Mar 27, 2014 | SVP, CFO & TREASURER | 4.00K | $17.00 | $68.00K | BUY | ∞ | 4.00K | Mar 25 | ||
Mar 26, 2014 | 10% OWNER | 1.52M | $17.00 | $3.10M | BUY | ∞ | 1.52M | Mar 25 |
FAQ
L'insider trading è legale?
L'insider trading è legale a condizione che gli insider segnalino le loro operazioni alla SEC. Il trading illegale di titoli si verifica quando l'insider viola un dovere fiduciario o non segnala le sue operazioni.
Quali sono alcuni esempi di manipolazione del mercato?
L'insider trading, gli schemi di pump and dump, il front running e i wash trade sono tutti esempi di manipolazione del mercato. Gli investitori che seguono i movimenti delle attività degli insider dovrebbero riflettere attentamente sul motivo per cui questi insider stanno negoziando le loro azioni prima di procedere.
Sfoglia insider trading su tutte le azioni.